Hemab
Drug DiscoveryWebsite
Hemab valuation and funding history | Last updated: October 27, 2025 | 2 funding rounds
Current Valuation
N/A
As of October 27, 2025
Total Funding Raised
$353.0M
Across 2 rounds
Last Round
Later Stage VC
$157.0M
Last Funding
Oct 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 27, 2025 | Later Stage VC (Series C) | $157.0M | N/A | - |
| February 15, 2023 | Early Stage VC (Series B) | $137.8M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Hemab is currently valued at N/A as of October 27, 2025. The company has raised a total of $353.0M in funding across 2 funding rounds.
What is Hemab Worth in 2026?
Hemab is a leading private company in the Drug Discovery sector. Track Hemab's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Hemab Valuation is Determined
Private company valuations like Hemab's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.